AlloMap molecular expression testing: Difference between revisions

Revision as of 08:46, 11 September 2010

Revision as of 01:06, 14 September 2010

Line 1:

{{Orphan|date=September 2010}}

<!-- Please do not remove or change this AfD message until the issue is settled -->

{{AfDM|page=AlloMap Molecular Expression Testing|year=2010|month=September|day=8|substed=yes|help=off}}

<!-- For administrator use only: {{Old AfD multi|page=AlloMap Molecular Expression Testing|date=8 September 2010|result='''keep'''}} -->

<!-- End of AfD message, feel free to edit beyond this point -->

'''AlloMap Molecular Expression Testing''', developed and commercialized by XDx, is a gene expression profiling test that helps doctors identify [[heart transplantation|heart transplant]] recipients with a low probability of heart [[organ transplant|transplant]] rejection.